Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 41.1744.02---

What is the latest Price to Cash Earnings (PCE) ratio of CONCORD BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of CONCORD BIOTECH is 41.17 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202541.17
Mar202444.02
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of CONCORD BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 41.17
-6.47
Mar2024 44.02
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of CONCORD BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹11,668.7 Cr -2.1% 4.5% -25% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,195.0 Cr 0.9% 12.7% 8.2% Stock Analytics
DIVIS LABORATORIES ₹182,993.0 Cr -0.4% 9.7% 11.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,926.0 Cr 0.5% 5.8% 36.5% Stock Analytics
CIPLA ₹113,052.0 Cr -2.7% 13.9% -6.2% Stock Analytics
DR REDDYS LABORATORIES ₹110,333.0 Cr 1.5% 7.3% 8% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-2.1%

4.5%

-25%

SENSEX

1%

-4.1%

-7.4%


You may also like the below Video Courses